WIMAGINE BCI is a key component of CEA’s ARC-BCI system, aiming to restore movement in paralysis patients.
|
|
Optune Lua received US Food and Drug Administration (FDA) approval based on data from the pivotal LUNAR trial, which demonstrated significant median overall survival (OS) improvement.
|
|
The test has a 99% negative predictive value and features longitudinal monitoring.
|
|
With its pulsed-field ablation system approved in the EU and US, Boston Scientific aims to lead the pack in atrial fibrillation treatment.
|
|
After a two-year delay, J&J is ready to disrupt Intuitive’s market domination with Da Vinci.
|
|
Theranostics pairs diagnostic tracers with radioisotopes to deliver molecular insights specific to a patient’s cancer cells.
|
|
A variety of AI models are being trained on cough sounds for the early detection of tuberculosis.
|
|